How to verify reference material traceability in diagnostic tests

A diagnostic result is not demonstrably traceable simply because its calibrator is described as “traceable to a reference material.” The claim must identify what is being measured, the reference to which the value is linked, and the documented calibration hierarchy connecting that reference to the reported result. Each relevant step contributes uncertainty, and the evidence must apply to the particular assay and material in use.

Verification therefore starts with certificates, value-assignment procedures and calibration records—not the supplier’s label alone. A strong claim also has a defined scope: traceability of a numerical value does not, by itself, establish clinical accuracy, interchangeability between methods or suitability for every specimen type.

Identify the measurement before examining the certificate

Metrological traceability is a property of a measurement result: it is established through a documented, unbroken chain of calibrations to a stated reference, with each calibration contributing to measurement uncertainty. A reference material can support that chain, but possessing the material is not the same as demonstrating the traceability of a patient result.

The starting point is the measurand: the quantity intended to be measured. Record the analyte, the biological specimen, the form of the result and the measurement unit. An assay reporting mass concentration in serum, for example, should not be assessed against a certificate for a different molecular form or a value expressed in an incompatible unit without a justified conversion.

This distinction is especially important for proteins and other heterogeneous biological substances. The name of an analyte alone may conceal differences in molecular variants, fragments or modifications recognized by different methods. A certificate can be authentic and still be a poor basis for assessing a specific assay if its assigned property is not aligned with what the assay detects.

Also distinguish quantitative results from qualitative calls. A positive or negative result derived from a numerical signal and a cutoff does not become metrologically traceable merely because a positive control has a stated concentration. The concentration or another input quantity may have a traceability claim; the validity of the cutoff and the diagnostic classification require separate evidence.

Read the certificate as a statement of scope, not a seal of approval

A certificate for a certified reference material should identify the material and its producer, the certified property value, associated uncertainty and the basis of metrological traceability. It should also state the material’s intended use and conditions that affect the value, such as storage, preparation, reconstitution and expiration or validity limits.

Match those details to the material actually received. The material identifier and lot or batch number should agree with the container and purchasing records. Confirm that the certificate covers the relevant property and unit, not merely a related characteristic. An informational value or a value assigned for a different purpose should not automatically be treated as a certified value for calibration.

Check how the material was characterized. The certificate or supporting documentation should explain the approach used to assign the value and assess uncertainty, including relevant contributions from characterization, homogeneity and stability. The level of detail available on the certificate can vary; where a critical link is unclear, request the supporting information needed to assess the claim.

Producer competence is relevant, but the scope matters. ISO 17034 specifies general requirements for the competence of reference material producers. An accreditation claim should be checked against the accrediting body’s information and the producer’s applicable scope. Accreditation of a producer is not, on its own, proof that every material or every assigned property it supplies is covered.

Reconstruct the chain to the assay’s working calibrator

The key question is how the reference value reaches the calibrator used by the diagnostic system. Depending on the measurand and available higher-order references, the chain can include a higher-order reference material or procedure, intermediate materials, a manufacturer’s standing or master calibrator, and a product calibrator used for routine testing.

For each link, establish the identity of the material or procedure, the organization responsible for value assignment, and the measurement procedure used to transfer the value. Calibration records should connect the relevant lots and show how assigned values were obtained. The chain should also identify the reference at its top: an SI unit where an appropriate route exists, or another stated reference, such as an internationally agreed conventional reference, where it does not.

A statement such as “calibrated against an international standard” is incomplete unless the standard, version or batch where relevant, assigned property and transfer procedure can be identified. Similarly, an accreditation symbol on a laboratory document is useful only when the relevant measurement or calibration falls within the accredited scope. ISO/IEC 17025 addresses competence of testing and calibration laboratories; it does not make every result issued by an accredited laboratory traceable for every purpose.

Full proprietary manufacturing records may not be available to an external reviewer. That limitation does not make the claim false, but it changes what can be independently verified. Ask the manufacturer for a traceability statement, a hierarchy diagram and sufficient supporting evidence to identify the links, responsibilities and uncertainties. Record any inaccessible link as a limit of the assessment rather than filling the gap with an assumption.

For in vitro diagnostic medical devices, ISO 17511 addresses the establishment of metrological traceability of values assigned to calibrators, trueness control materials and human samples. Its framework is useful for checking whether a manufacturer’s hierarchy is coherent. Applicability of a particular edition or standard to a product should be assessed against the relevant jurisdiction and product documentation.

Examine uncertainty across the chain

An assigned value without an associated uncertainty does not provide enough information to assess the strength of a quantitative traceability claim. Review the uncertainty stated for the reference material and how uncertainty is propagated or otherwise evaluated as the value moves through the hierarchy.

Relevant contributions can include the uncertainty of the higher-order reference, imprecision and bias in value transfer, material heterogeneity, stability and uncertainty associated with calibration of the routine procedure. The exact model depends on the process. Avoid adding all reported numbers mechanically: uncertainty components may be expressed in different forms, may be correlated, or may already be included in a downstream estimate.

Check whether the reported figure is a standard uncertainty or an expanded uncertainty. For an expanded uncertainty, look for the coverage factor and, where stated, the intended coverage probability. Units and concentration levels matter as well: an uncertainty acceptable at one concentration cannot automatically be applied across the measuring interval.

Compare the resulting uncertainty with the test’s intended use and established performance requirements. Traceability does not guarantee that the uncertainty is small enough to support a clinical decision near a cutoff or decision limit. Nor does a narrow uncertainty on the reference certificate account for errors introduced later by the routine measuring system.

Check matrix effects and commutability

A value can be traceable and still transfer poorly to patient samples. The material’s matrix—the substances surrounding the analyte—can affect how different measurement procedures respond. A processed, spiked or freeze-dried material may behave differently from native patient specimens.

Commutability concerns whether a reference material shows a relationship between results from different measurement procedures that is consistent with the relationship observed for representative clinical samples. It is not a universal property of the vial: it depends on the procedures being compared and the intended use.

For example, if a manufacturer uses a reference material to transfer a value from a reference procedure to a routine immunoassay, evidence is needed that the transfer is appropriate for that combination. A noncommutable material can produce an apparently sound calibration chain while leaving a systematic difference in patient results. Conversely, evidence of commutability for one pair of methods does not automatically extend to another assay or a different formulation.

Request the basis for the commutability assessment where it is relevant to the claimed use: the procedures compared, the types and range of clinical samples, the material preparation and the acceptance approach. If the material is intended only for a specific procedure, its restricted use should be reflected in the traceability assessment.

Recognize where the available reference ends

Not every diagnostic measurand has a reference measurement procedure or material linked to SI units. Some results are standardized against an internationally agreed reference preparation and reported in internationally defined units. Such traceability can be meaningful, but the stated reference and its limitations must remain visible; international units are not automatically interchangeable with mass concentration.

Molecular tests illustrate why the assigned quantity matters. A reference preparation may carry an assigned number of copies or an international-unit value, while a routine assay reports detection or nondetection after extraction and amplification. Evidence linking an input concentration to a reference does not by itself validate extraction efficiency, the limit of detection, variant coverage or the final qualitative interpretation.

Where no suitable higher-order reference exists, a manufacturer may rely on a specified measurement procedure, a designated material or another documented convention. The resulting claim should identify that endpoint rather than imply a link that does not exist. Comparability between different assays may remain limited, particularly when procedures recognize different forms of an analyte.

Maintain the evidence through routine use

Traceability documentation needs to remain connected to the test configuration that generated results. Keep the reference material certificate, lot identification, receipt and storage records, preparation records, calibration assignments and applicable manufacturer instructions together with the assay and instrument identifiers. Record deviations such as an excursion outside stated storage conditions and assess their effect before relying on the assigned value.

Changes can invalidate an earlier assessment. A new calibrator lot, revised value assignment, altered formulation, new reference material batch or significant measurement-procedure change may require review of the affected links. Lot-to-lot comparison and routine quality control help detect changes in performance, but they do not replace evidence for the traceability hierarchy.

External quality assessment or proficiency testing provides another distinct check. Agreement with a peer group can reveal or conceal bias depending on the comparison design and assigned values. A favorable result is not, by itself, proof of traceability; a poor result also needs investigation before its cause can be attributed to the reference chain.

A defensible assessment ends with a specific statement: which result or calibrator value is linked to which reference, through what documented hierarchy, with what uncertainty and under which conditions. Where evidence is incomplete, record the affected link, the potential consequence for the reported result and the action taken to obtain evidence or limit use. That record is more informative than an unqualified “traceable” designation.